FDA orders all Juul e-cigarettes off the market
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
Today's Liberal News
By Katherine Ellen Foley
FDA orders all Juul e-cigarettes off the market
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
FDA orders all Juul e-cigarettes off the market
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
FDA orders all Juul e-cigarettes off the market
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlers
Shots will be be available for children from 6 months to 5 years as early as next week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children
The companies plan to finish submitting data to the Food and Drug Administration this week.
Moderna ‘happy’ with results from its kids vaccine trial, but is it enough for the FDA?
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
Moderna ‘happy’ with results from its kids vaccine trial, but is it enough for the FDA?
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
Moderna ‘happy’ with results from its kids vaccine trial, but is it enough for the FDA?
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
Moderna ‘happy’ with results from its kids vaccine trial, but is it enough for the FDA?
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
FDA authorizes additional booster of Pfizer-BioNTech, Moderna Covid-19 vaccine for adults 50 and older
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
FDA authorizes additional booster of Pfizer-BioNTech, Moderna Covid-19 vaccine for adults 50 and older
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
Moderna ‘happy’ with results from its kids vaccine trial, but is it enough for the FDA?
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
FDA authorizes additional booster of Pfizer-BioNTech, Moderna Covid-19 vaccine for adults 50 and older
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
Moderna to seek emergency authorization for Covid vaccine for young kids
The company says its shot is safe, effective for youngest children.
Pfizer to begin late-stage testing of Covid-19 antiviral for kids
The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.
Pfizer to begin late-stage testing of Covid-19 antiviral for kids
The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.